Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Momentum Builds For Tomorrow's More Convenient Hemophilia Drugs

Jul 13 2017

• By Emily Hayes

3-D Rendering Red Blood Cells

Related Content

Roche's Emicizumab Progresses Against Hemophilia's Next Big Challenge: Patients With Factor VIII Inhibitors

Apr 18 2017

Phase III Updates Bode Well For Filings Of Roche's Emicizumab In Hemophilia

Jul 11 2017

Alnylam's Fitusiran Could Provide Comprehensive Hemophilia Therapy Option

Aug 29 2016

Patient Death Casts Cloud Over Roche Emicizumab Hemophilia Trial

Feb 24 2017

Related Companies

Roche Holding AG

Alnylam Pharmaceuticals Inc.

Sanofi

BioMarin Pharmaceutical Inc.

Spark Therapeutics, Inc.

Sanofi

Novo Nordisk A/S

Genentech, Inc.

Pfizer Inc.

Additional Topics

Research & Development Clinical Trials Innovation Rare Diseases Blood & Coagulation Disorders BioPharmaceutical

More from R&D

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window